Ultragenyx Pharmaceutical (RARE) Q2 2020 Earnings

6MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-1.96
-1.85
-1.73
-1.62

Details

Expected EPS
-1.69
Actual EPS
-1.91
Surprise EPS
-0.22
Surprise Percent
+13.02%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.91 per share for Q2 2020.

0 Comments

Share your thoughts